Striatal Neuronal Ensembles Reveal Differential Actions of Amantadine and Clozapine to Ameliorate Mice L-DOPA-Induced Dyskinesia

• Published in: Neuroscience 2022-06, Vol.492, p.92-107
• Main Authors: Calderón, Vladimir M., Luna-Leal, Aldo, Gómez-Paz, Alejandra, Ramírez-López, Fernanda, Arias-García, Mario, Lara-González, Esther, Galarraga, Elvira, Bargas, José
• Format: Article
• Language: English
• Subjects: calcium imaging; dyskinetic striatal microcircuit; identification of antidyskinetic drugs actions; L-DOPA-Induced Dyskinesia; neuronal ensembles
• ISSN: 0306-4522; 1873-7544
• DOI: 10.1016/j.neuroscience.2022.03.036

[Display omitted] •Amantadine and clozapine have equivalent behavioral effects in LID mouse.•Ca2+ imaging of LID striatal microcircuit shows specific dyskinetic features.•Proposed analysis pipeline of neuronal ensembles extracts these features.•Neuronal ensembles features differentiate the actions of amantadine and clozapine.•A supervised classification algorithm separates accurately drug actions in vitro. Amantadine and clozapine have proved to reduce abnormal involuntary movements (AIMs) in preclinical and clinical studies of L-DOPA-Induced Dyskinesias (LID). Even though both drugs decrease AIMs, they may have different action mechanisms by using different receptors and signaling profiles. Here we asked whether there are differences in how they modulate neuronal activity of multiple striatal neurons within the striatal microcircuit at histological level during the dose-peak of L-DOPA in ex-vivo brain slices obtained from dyskinetic mice. To answer this question, we used calcium imaging to record the activity of dozens of neurons of the dorsolateral striatum before and after drugs administration in vitro. We also developed an analysis framework to extract encoding insights from calcium imaging data by quantifying neuronal activity, identifying neuronal ensembles by linking neurons that coactivate using hierarchical cluster analysis and extracting network parameters using Graph Theory. The results show that while both drugs reduce LIDs scores behaviorally in a similar way, they have several different and specific actions on modulating the dyskinetic striatal microcircuit. The extracted features were highly accurate in separating amantadine and clozapine effects by means of principal components analysis (PCA) and support vector machine (SVM) algorithms. These results predict possible synergistic actions of amantadine and clozapine on the dyskinetic striatal microcircuit establishing a framework for a bioassay to test novel antidyskinetic drugs or treatments in vitro.